Wow. Wrong again. Further reason (if I needed another) as to why I’m not a trader. Got me a little stumped actually, could be concerns about the future cap raises required? The IDE is fantastic news and I don’t think I can be convinced otherwise (do correct me but if I’m missing something). In the meantime I’ll just stick with trying to get rich slowly.

Perhaps it’s the market judging Anteris for its creative over-reach in acronym creation? I mean, there is some fair criticism to be had there, but this seems harsh.

@PabloEskyBruh unusual, but not a complete surprise to me. I think the catalyst we might have expected is muted by the long and uncertain time to PMA/501k, and unknown level of future capital to be raised.(I write with great confidence looking with 20/20 vision into the rear view mirror!)

It will be interesting to see over the coming months if we get more data on enrolments (presumably, yes). That will allow the market to better extrapolate trial duration and that will create SP catalysts,…one way or the other.

It is a great example of how market reactions can vary hugely between US and ASX dual-listings. We also have seen that in the last few days with $RMD and, in the past, I have often seen it with $AVH. So much for the Efficient Market Theory!

Disc. Not held.

I had exactly the same thought

Can't understand how AVR is not worth more now. The need for future cap raises was always going to be there

If it goes much lower, I might buy a little more